Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 12

1.
2.

Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Lasserson TJ.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007695. doi: 10.1002/14651858.CD007695.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD007695.

PMID:
19821436
3.

Regular treatment with salmeterol for chronic asthma: serious adverse events.

Cates CJ, Cates MJ.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006363. doi: 10.1002/14651858.CD006363.pub2. Review.

4.

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.

Walters EH, Gibson PG, Lasserson TJ, Walters JA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001385. Review.

PMID:
17253458
5.

Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE.

Ann Intern Med. 2006 Jun 20;144(12):904-12. Epub 2006 Jun 5.

PMID:
16754916
6.

Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005535. Review. Update in: Cochrane Database Syst Rev. 2010;(5):CD005535.

PMID:
16235410
7.
8.

Eformoterol Turbohaler compared with salmeterol by dry powder inhaler in asthmatic children not controlled on inhaled corticosteroids.

Everden P, Campbell M, Harnden C, McGoldrick H, Bodalia B, Manion V, Reynia S; FACT study group.

Pediatr Allergy Immunol. 2004 Feb;15(1):40-7.

PMID:
14998381
10.

A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.

Campbell LM, Anderson TJ, Parashchak MR, Burke CM, Watson SA, Turbitt ML.

Respir Med. 1999 Apr;93(4):236-44. Erratum in: Respir Med 1999 May;93(5):370. Corrected and republished in: Respir Med. 1999 Jul;93(7):236-44.

PMID:
10464887
11.

Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.

Rutten-van Mölken MP, van Doorslaer EK, Till MD.

Pharmacoeconomics. 1998 Dec;14(6):671-84.

PMID:
10346418
12.

A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease.

Vervloet D, Ekström T, Pela R, Duce Gracia F, Kopp C, Silvert BD, Quebe-Fehling E, Della Cioppa G, Di Benedetto G.

Respir Med. 1998 Jun;92(6):836-42.

PMID:
9850367

Supplemental Content

Support Center